Hormonal control of androgen receptor function through SIRT1

被引:198
作者
Fu, Maofu
Liu, Manran
Sauve, Anthony A.
Jiao, Xuanmao
Zhang, Xueping
Wu, Xiaofang
Powell, Michael J.
Yang, Tianle
Gu, Wei
Avantaggiati, Maria Laura
Pattabiraman, Nagarajan
Pestell, Timothy G.
Wang, Fang
Quong, Andrew A.
Wang, Chenguang
Pestell, Richard G.
机构
[1] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dept Med Oncol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[3] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA
[4] Columbia Univ Coll Phys & Surg, Dept Pathol, Inst Canc Genet, New York, NY 10032 USA
[5] Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA
[6] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA
关键词
D O I
10.1128/MCB.00289-06
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The NAD-dependent histone deacetylase Sir2 plays a key role in connecting cellular metabolism with gene silencing and aging. The androgen receptor (AR) is a ligand-regulated modular nuclear receptor governing prostate cancer cellular proliferation, differentiation, and apoptosis in response to androgens, including dihydrotestosterone (DHT). Here, SIRT1 antagonists induce endogenous AR expression and enhance DHT-mediated AR expression. SIRT1 binds and deacetylates the AR at a conserved lysine motif. Human SIRT1 (hSIRT1) repression of DHT-induced AR signaling requires the NAD-dependent catalytic function of hSIRT1 and the AR lysine residues deacetylated by SIRT1. SIRT1 inhibited coactivator-induced interactions between the AR amino and carboxyl termini. DHT-induced prostate cancer cellular contact-independent growth is also blocked by SIRT1, providing a direct functional link between the AR, which is a critical determinant of progression of human prostate cancer, and the sirtuins..
引用
收藏
页码:8122 / 8135
页数:14
相关论文
共 58 条
  • [41] Mammalian SIRT1 represses forkhead transcription factors
    Motta, MC
    Divecha, N
    Lemieux, M
    Kamel, C
    Chen, D
    Gu, W
    Bultsma, Y
    McBurney, M
    Guarente, L
    [J]. CELL, 2004, 116 (04) : 551 - 563
  • [42] Acetylation of TAFI68, a subunit of TIF-IB/SL1, activates RNA polymerase I transcription
    Muth, V
    Nadaud, S
    Grummt, I
    Voit, R
    [J]. EMBO JOURNAL, 2001, 20 (06) : 1353 - 1362
  • [43] UCSF chimera - A visualization system for exploratory research and analysis
    Pettersen, EF
    Goddard, TD
    Huang, CC
    Couch, GS
    Greenblatt, DM
    Meng, EC
    Ferrin, TE
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 2004, 25 (13) : 1605 - 1612
  • [44] Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner
    Reutens, AT
    Fu, MF
    Wang, CG
    Albanese, C
    McPhaul, MJ
    Sun, ZJ
    Balk, SP
    Jänne, OA
    Palvimo, JJ
    Pestell, RG
    [J]. MOLECULAR ENDOCRINOLOGY, 2001, 15 (05) : 797 - 811
  • [45] The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells
    Revollo, JR
    Grimm, AA
    Imai, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (49) : 50754 - 50763
  • [46] Rossi S, 2003, MOL CANCER RES, V1, P707
  • [47] Sathya G, 2003, CANCER RES, V63, P8029
  • [48] Chemical activation of Sir2-dependent silencing by relief of nicotinamide inhibition
    Sauve, AA
    Moir, RD
    Schramm, VL
    Willis, IM
    [J]. MOLECULAR CELL, 2005, 17 (04) : 595 - 601
  • [49] Chemistry of gene silencing:: The mechanism of NAD+-dependent deacetylation reactions
    Sauve, AA
    Celic, I
    Avalos, J
    Deng, HT
    Boeke, JD
    Schramm, VL
    [J]. BIOCHEMISTRY, 2001, 40 (51) : 15456 - 15463
  • [50] Androgen therapy improves muscle mass and strength but not muscle quality: results from two studies
    Schroeder, ET
    Terk, M
    Sattler, FR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 285 (01): : E16 - E24